Blog Elements
You can display blog posts in various ways with the “Blog Post” element/shortcode. You can see one example here and even more at the blog main menu item of this demo.
https://www.sifact.it/wp-content/uploads/2024/02/comunicazione.jpg
590
965
Segreteria SIFaCT
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Segreteria SIFaCT2024-02-27 13:08:552024-04-23 08:43:12Comunicazione Medico-Paziente nel carcinoma mammario HR+/HER2 Negativo – Quello che le pazienti non dicono… – 16/04/2024
https://www.sifact.it/wp-content/uploads/2024/02/antimicrobial.jpg
890
1272
Segreteria SIFaCT
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Segreteria SIFaCT2024-02-27 13:02:002024-04-05 13:36:03ANTIMICROBIAL RESISTENCE: PNCAR, STEWARDSHIP & SETTING ASSISTENZIALI: ESPERIENZE A CONFRONTO E OBIETTIVI REGIONALI – 18/03/2024
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Segreteria SIFaCT
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Segreteria SIFaCT2024-02-21 15:19:132024-02-21 15:25:22Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free Survival
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Segreteria SIFaCT
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Segreteria SIFaCT2024-02-21 15:11:282024-02-21 15:13:25EFFICACY OF DEPRESCRIBING ON HEALTH OUTCOMES: AN UMBRELLA REVIEW OF SYSTEMATIC REVIEWS WITH META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Segreteria SIFaCT
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Segreteria SIFaCT2024-02-20 12:43:462024-02-20 12:43:48Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Segreteria SIFaCT
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Segreteria SIFaCT2024-02-20 12:40:312024-02-20 12:51:31Tislelizumab plus chemotherapy vs. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials
Corso di aggiornamento “MASTERPHARM 2025 – 4a EDIZIONE – 1° modulo”, Baveno 14-16 maggio 2025